BioMedical Strategy was established in 2004, and since then has gained a vast experience in successfully collaborating with the medical device companies in their Clinical and Regulatory tasks. The BioMedical Strategy team is comprised of postdoctoral academic researchers all highly trained in the fields of clinical and regulatory affairs.
We are aimed to support biomedical companies in building coherent and valuable Pre Clinical, Clinical and Regulatory strategies, Regulatory submissions, Clinical submissions, as well as high level management and monitoring of clinical studies.